Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DABIGATRAN ETEXILATE Cause Death? 1,025 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 1,025 reports of Death have been filed in association with DABIGATRAN ETEXILATE (dabigatran etexilate). This represents 2.8% of all adverse event reports for DABIGATRAN ETEXILATE.

1,025
Reports of Death with DABIGATRAN ETEXILATE
2.8%
of all DABIGATRAN ETEXILATE reports
1,025
Deaths
284
Hospitalizations

How Dangerous Is Death From DABIGATRAN ETEXILATE?

Of the 1,025 reports, 1,025 (100.0%) resulted in death, 284 (27.7%) required hospitalization, and 47 (4.6%) were considered life-threatening.

Is Death Listed in the Official Label?

Yes, Death is listed as a known adverse reaction in the official FDA drug label for DABIGATRAN ETEXILATE.

What Other Side Effects Does DABIGATRAN ETEXILATE Cause?

Gastrointestinal haemorrhage (4,081) Cerebrovascular accident (2,175) Fall (1,786) Ischaemic stroke (1,581) Anaemia (1,412) Haemorrhage (1,324) Rectal haemorrhage (964) Cerebral haemorrhage (946) Upper gastrointestinal haemorrhage (861) Atrial fibrillation (858)

What Other Drugs Cause Death?

OXYCODONE (23,259) LENALIDOMIDE (19,213) APIXABAN (18,501) MORPHINE (17,960) ACETAMINOPHEN\OXYCODONE (17,849) FENTANYL (16,577) DENOSUMAB (16,545) ACETAMINOPHEN\HYDROCODONE (16,341) HYDROMORPHONE (15,276) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (13,789)

Which DABIGATRAN ETEXILATE Alternatives Have Lower Death Risk?

DABIGATRAN ETEXILATE vs DABRAFENIB DABIGATRAN ETEXILATE vs DABRAFENIB\TRAMETINIB DABIGATRAN ETEXILATE vs DACARBAZINE DABIGATRAN ETEXILATE vs DACLATASVIR DABIGATRAN ETEXILATE vs DACLIZUMAB

Related Pages

DABIGATRAN ETEXILATE Full Profile All Death Reports All Drugs Causing Death DABIGATRAN ETEXILATE Demographics